Innovation Medical Management Co., Ltd. carries a market capitalization of 8.55B, placing it among publicly traded companies globally. Its enterprise value stands at 6.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.55B |
| Enterprise Value | 6.23B |
Innovation Medical Management Co., Ltd. currently has 441.28M shares outstanding.
| Shares Outstanding | 441.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 8.18, and the price-to-book ratio stands at -6.84.
| PE Ratio | N/A |
| PS Ratio | 8.18 |
| PB Ratio | -6.84 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 108.90 |
| P/OCF Ratio | N/A |
| EV / Sales | 7.70 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 96.36 |
Innovation Medical Management Co., Ltd. maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.23, indicating elevated leverage, while an interest coverage ratio of -14.46 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.99 |
| Quick Ratio | 1.60 |
| Debt / Equity | 4.23 |
| Debt / EBITDA | -1.23 |
| Interest Coverage | -14.46 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -4.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 6.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 22.64 |
Over the trailing twelve months, Innovation Medical Management Co., Ltd. has paid -6.85M in income taxes, reflecting an effective tax rate of 19.77.
| Income Tax | -6.85M |
| Effective Tax Rate | 19.77 |
Innovation Medical Management Co., Ltd.'s stock has gained approximately 27.75214% over the past 52 weeks. The 50-day moving average sits at 20.46, while the 200-day moving average is 24.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | 27.75214% |
| 50-Day Moving Average | 20.46 |
| 200-Day Moving Average | 24.11 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Innovation Medical Management Co., Ltd. generated 809.51M in revenue and converted that into -89.29M in net income, yielding earnings per share of -0.19. EBITDA reached -60.72M, while operating income came in at -60.72M.
| Revenue | 809.51M |
| Gross Profit | 64.00M |
| Operating Income | -60.72M |
| Pretax Income | -96.15M |
| Net Income | -89.29M |
| EBITDA | -60.72M |
| EBIT | -60.72M |
| Earnings Per Share (EPS) | -0.19 |
Innovation Medical Management Co., Ltd. holds 462.18M in cash and equivalents against 74.64M in total debt, resulting in a net debt position of -194.99M. Total book value stands at -968.27M, with working capital of 286.30M providing operational flexibility.
| Cash & Cash Equivalents | 462.18M |
| Total Debt | 74.64M |
| Net Debt | -194.99M |
| Equity (Book Value) | -968.27M |
| Book Value Per Share | -2.08 |
| Working Capital | 286.30M |
After subtracting -60.79M in capital expenditures, free cash flow totaled -60.79M - equivalent to -0.13 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -60.79M |
| Free Cash Flow | -60.79M |
| FCF Per Share | -0.13 |
Innovation Medical Management Co., Ltd. operates with a gross margin of 7.91, reflecting its pricing power and cost economics. The operating margin of -7.50 and net profit margin of -11.03 provide insight into operational efficiency.
| Gross Margin | 7.91 |
| Operating Margin | -7.50 |
| Pretax Margin | -11.88 |
| Profit Margin | -11.03 |
| EBITDA Margin | -7.50 |
The company's payout ratio of -3.16 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | -3.16 |
| Shareholder Yield | 0.17 |
| FCF Yield | 0.92 |
Innovation Medical Management Co., Ltd.'s most recent stock split took place on May 6, 2011 with a 1:2 split ratio.
| Last Split Date | 5/6/2011 |
| Split Ratio | 1:2 |
Innovation Medical Management Co., Ltd. posts an Altman Z-Score of 9.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.72 |